Delivery Order SPE2DB25D3021-SPE2DB25FQZEX
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $70,700.93 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. The contract represents a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, the company's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract from the Defense Logistics Agency (DLA) on September 18, 2025, valued at $16,823.38 for RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 19, 2025. The award is issued as a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 2, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply RINVOQ ER 30 mg tablets in quantities of 30-unit packages. The contract is valued at $7,943.17 with a firm fixed price structure and an ultimate completion date of September 3, 2025. This is a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $3,700.62 delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose packages). The contract represents a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 18, 2025. This award was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 29, 2025, by the Defense Logistics Agency (DLA) for the supply of RINVOQ ER 45 MG tablets (28-count units). The contract, valued at $60,445.18, is structured as a firm fixed price delivery order with an ultimate completion date of September 2, 2025. This award represents a non-set-aside, competitively awarded procurement and is issued as a child order under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $14,917.09 for RINVOQ ER 30 MG Tablet (UU 30s) by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and is classified as a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 30, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose) valued at $11,415.23. This firm fixed-price contract award was competitively procured with no set-aside designation and carries an ultimate completion date of July 31, 2025. The delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 3, 2025, valued at $91,328.55 for RINVOQ ER 15 mg tablets (30-count units) under a firm fixed price contract type. The award, issued by the Defense Logistics Agency (DLA), was competitively awarded with no set-aside designation and has an ultimate completion date of September 4, 2025. This delivery order serves as a child contract under...
- AmerisourceBergen Drug Corp was awarded a $8,405.21 delivery order on July 14, 2025, for RINVOQ ER 15 mg tablets (30-count units) under a competitively awarded, non-set-aside contract vehicle. The contract was funded by the Defense Medical Supply Chain and is set to be completed by July 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order utilizes firm fixed-price pricing and represents a child contract under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $9,334.98. The award is competitively bid with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. This delivery order represents a single...